Revista da Sociedade Brasileira de Medicina Tropical (Apr 2019)

Use of pharmaceutical nanotechnology for the treatment of leishmaniasis

  • Carine Santana Ferreira Marques,
  • Jorge Barreto Machado Júnior,
  • Lucas Rannier de Melo Andrade,
  • Luciana Nalone Andrade,
  • André Luis Souza dos Santos,
  • Maria do Socorro Pires e Cruz,
  • Marco Chaud,
  • Alini Tinoco Fricks,
  • Patrícia Severino

DOI
https://doi.org/10.1590/0037-8682-0246-2018
Journal volume & issue
Vol. 52, no. 0

Abstract

Read online

Abstract INTRODUCTION: Leishmaniasis is a global public health concern. Currently available treatments are associated with considerable side effects. The use of nanotechnology has shown promise for improving efficacy and bioavailability and minimizing side effects. METHODS: This study investigated available literature, including patents and scientific articles, to identify advances in the use of nanotechnology for the treatment of leishmaniasis. RESULTS: Our findings revealed a stable number of patents and scientific articles published over the past five years. CONCLUSIONS: There is a need to intensify research on the use of nanotechnology for the treatment of leishmaniasis.

Keywords